4.0 Article

A single institution experience with pediatric nasopharyngeal carcinoma: High incidence of toxicity associated with platinum-based chemotherapy plus IMRT

Journal

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
Volume 29, Issue 7, Pages 500-505

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MPH.0b013e3180959af4

Keywords

pediatrics; nasopharyngeal carcinoma; IMRT; long-term effects

Funding

  1. NCI NIH HHS [CA61384, P01 CA 94237, P01 CA094237, P01 CA094237-06] Funding Source: Medline
  2. NCRR NIH HHS [RR00188] Funding Source: Medline
  3. NIDDK NIH HHS [T32 DK064717, T32 DK064717-05, T32 DK64717] Funding Source: Medline

Ask authors/readers for more resources

Background: Chemotherapy and intensity-modulated radiotherapy (IMRT) have decreased treatment-related complications in adult patients with nasopharyngeal carcinoma (NPC). Our aim was to evaluate the toxicity profile of IMRT plus chemotherapy in pediatric NPC patients. Observations: Five patients were treated with chemotherapy and IMRT. All patients experienced grade 3-4 acute toxicities. With a median follow-up of 6.3 years, all patients experienced >= 3 long-term toxicities. The most common toxicities were hypothyroidism, xerostomia, hearing loss, and dental disease. Conclusions: We did not observe a significant decrease in long-term toxicities with IMRT plus chemotherapy in our small cohort of pediatric NPC patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available